KOPRAN
Back to Cashflow Statement
|
KOPRAN Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹11 Cr | ₹0.69 Cr | ₹1.53 Cr | ₹4.93 Cr | ₹0.10 Cr |
What is the latest Net Cash Inflow / Outflow ratio of KOPRAN ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹11 Cr |
| Mar2024 | ₹0.69 Cr |
| Mar2023 | ₹1.53 Cr |
| Mar2022 | ₹4.93 Cr |
| Mar2021 | ₹0.10 Cr |
How is Net Cash Inflow / Outflow of KOPRAN Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹11 Cr | 1,537.70 | |
| Mar2024 | ₹0.69 Cr | -54.52 | |
| Mar2023 | ₹1.53 Cr | -69.02 | |
| Mar2022 | ₹4.93 Cr | 4,784.16 | |
| Mar2021 | ₹0.10 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹961.4 Cr | -1.1% | 6.5% | 11.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹474,396.0 Cr | 0.6% | 6% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,990.0 Cr | 1.2% | 10.5% | 7.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,354.0 Cr | -0.4% | 11% | 40.8% | Stock Analytics | |
| CIPLA | ₹116,705.0 Cr | -1.6% | -2.1% | -4.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹94,790.0 Cr | -4.6% | -14.8% | -8.4% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -1.1% |
6.5% |
11.7% |
| SENSEX | -0.9% |
-0.4% |
-6.1% |
You may also like the below Video Courses